PPARGC1A and metabolic disease: Despite the critical roles of SIRT1 in metabolic regulation, there have been no studies suggesting that the beneficial effects of probiotics on risk factors for metabolic disorders are mediated by the positive modulation of SIRT1/PGC-1α pathway.